Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN)

CAPS Rating: 2 out of 5

A biopharmaceutical company focuses on the discovery, development and commercialization of innovative treatments for infectious diseases

Recs

0
Player Avatar Kvedarna (99.54) Submitted: 11/4/2013 10:03:18 AM : Underperform Start Price: $2.74 ACHN Score: +8.65

Sell on news

Featured Broker Partners


Advertisement